Portal de Periódicos da CAPES

Translocation of Ultrafine Particles

2006; National Institute of Environmental Health Sciences; Volume: 114; Issue: 4 Linguagem: Inglês

10.1289/ehp.114-a211b

1552-9924

Abderrahim Nemmar, Peter Hoet, Benoît Nemery,

Inhalation and Respiratory Drug Delivery

Vol. 114, No. 4 PerspectivesOpen AccessTranslocation of Ultrafine Particlesis companion ofUltrafine Particles: Geiser et al. Respond Abderrahim Nemmar, Peter H.M. Hoet, and Benoit Nemery Abderrahim Nemmar , Peter H.M. Hoet , and Benoit Nemery Published:1 April 2006https://doi.org/10.1289/ehp.114-a211bCited by:14AboutSectionsPDF ToolsDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InReddit We read with great interest the article by Geiser et al. (2005) on the mechanism of translocation of ultrafine particles (UFPs) across cellular membranes in vivo in rats following inhalation and in vitro using porcine pulmonary macrophages and human red blood cells.We are delighted to see this study that vindicates our hypothesis that translocation of UFPs is a possible pathway for the cardiovascular effects of particulate air pollution. A few years ago we reported extrapulmonary translocation of UFPs after intratracheal instillation in hamsters (Nemmar et al. 2001) and after inhalation in healthy human volunteers (Nemmar et al. 2002a), suggesting an alternative and/or a complementary explanation for the extrapulmonary effects of particles.In their study, Geiser et al. (2005) very elegantly provided novel morphologic data showing the occurrence of translocation of UFPs, and they also reported—for the first time—that this translocation did not occur by endocytic processes but rather by diffusion or adhesive interactions. However, we noted with some surprise that the authors cited Brown et al. (2002) when referring to previous studies on the occurrence of UFP translocation. Indeed, Brown et al. (2002) studied the deposition and clearance of an ultrafine (60 nm) technetium-99m–labeled aerosol in human volunteers after 2 hr, and found no significant radioactivity in the liver (1.3 ± 1.2%). This activity was attributed to scatter from the lung and/or overlap of lung parenchyma in the liver. Consequently, Brown et al. (2002) excluded the occurrence of translocation and, although they did not measure radioactivity in blood, they challenged our conclusion that UFPs (5–10 nm) could pass from the lungs into blood and extrapulmonary organs (Nemmar et al. 2002a). Therefore, for the sake of accuracy, Geiser et al. (2005) should have referred to our study (Nemmar et al. 2002a) rather than that of Brown et al. (2002).Geiser et al. (2005) provided micrographs of fluorescent polystyrene particles taken up by macrophages (Figure 3) or red blood cells (Figure 4). It is not clear whether these polystyrene particles contained surface charges, for example, carboxylate-modified (negatively charged) or amine-modified (positively charged), although Geiser et al. (2005) briefly discussed the possible effect of surface charge. This aspect is important; we (Nemmar et al. 2002b) and others (Silva et al. 2005) have reported that hemostasis may be affected by the intravenous or intratracheal administration of UFPs and also established that this phenomenon is dependent on the surface properties of the particles. Thus, only positively charged amine-modified particles led to a marked increase in prothrombotic tendency, which we showed to result, at least in part, from platelet activationIn conclusion, although the article by Geiser et al. (2005) adds a significant amount of information to the literature related to the extrapulmonary effect of inhaled particles, this issue needs to be clarified in more detail. Therefore, we look forward to this group and others providing more detailed quantification of the proportion of inhaled UFPs that can be found in extrapulmonary organs.ReferencesBrown JS, Zeman KL, Bennett WD. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240-124712403694. Crossref, Medline, Google ScholarGeiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz Het al.. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555-156016263511. Link, Google ScholarNemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MFet al.. 2002a. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411-41411815420. Crossref, Medline, Google ScholarNemmar A, Hoylaerts MF, Hoet PHM, Dinsdale D, Smith T, Xu Het al.. 2002b. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 166:98-100412091178. Crossref, Medline, Google ScholarNemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery B. 2001. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med 164:1665-166811719307. Crossref, Medline, Google ScholarSilva VM, Corson N, Elder A, Oberdorster G. 2005. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci 85:983-98915772370. Crossref, Medline, Google ScholarFiguresReferencesRelatedDetailsCited by Tang F, Wen X, Zhang X, Qi S, Tang X, Huang J, Zhu C, Shang G, Xu Y, Cai J and Wang R (2022) Ultrafine particles exposure is associated with specific operative procedures in a multi-chair dental clinic, Heliyon, 10.1016/j.heliyon.2022.e11127, 8:10, (e11127), Online publication date: 1-Oct-2022. Kanninen K, Lampinen R, Rantanen L, Odendaal L, Jalava P, Chew S and White A (2020) Olfactory cell cultures to investigate health effects of air pollution exposure: implications for neurodegeneration, Neurochemistry International, 10.1016/j.neuint.2020.104729, (104729), Online publication date: 1-Mar-2020. Bai L, Weichenthal S, Kwong J, Burnett R, Hatzopoulou M, Jerrett M, van Donkelaar A, Martin R, Van Ryswyk K, Lu H, Kopp A and Chen H (2018) Associations of Long-Term Exposure to Ultrafine Particles and Nitrogen Dioxide With Increased Incidence of Congestive Heart Failure and Acute Myocardial Infarction, American Journal of Epidemiology, 10.1093/aje/kwy194, 188:1, (151-159), Online publication date: 1-Jan-2019. Poh T, Ali N, Mac Aogáin M, Kathawala M, Setyawati M, Ng K and Chotirmall S (2018) Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives, Particle and Fibre Toxicology, 10.1186/s12989-018-0282-0, 15:1, Online publication date: 1-Dec-2018. Bengalli R, Gualtieri M, Capasso L, Urani C and Camatini M (2017) Impact of zinc oxide nanoparticles on an in vitro model of the human air-blood barrier, Toxicology Letters, 10.1016/j.toxlet.2017.07.877, 279, (22-32), Online publication date: 1-Sep-2017. Lomnicki S, Gullett B, Stöger T, Kennedy I, Diaz J, Dugas T, Varner K, Carlin D, Dellinger B and Cormier S (2014) Combustion By-Products and Their Health Effects—Combustion Engineering and Global Health in the 21st Century, International Journal of Toxicology, 10.1177/1091581813519686, 33:1, (3-13), Online publication date: 1-Jan-2014. Napierska D, Quarck R, Thomassen L, Lison D, Martens J, Delcroix M, Nemery B and Hoet P (2012) Amorphous Silica Nanoparticles Promote Monocyte Adhesion to Human Endothelial Cells: Size-Dependent Effect, Small, 10.1002/smll.201201033, 9:3, (430-438), Online publication date: 11-Feb-2013. Stapleton P, Minarchick V, Cumpston A, McKinney W, Chen B, Sager T, Frazer D, Mercer R, Scabilloni J, Andrew M, Castranova V and Nurkiewicz T (2012) Impairment of Coronary Arteriolar Endothelium-Dependent Dilation after Multi-Walled Carbon Nanotube Inhalation: A Time-Course Study, International Journal of Molecular Sciences, 10.3390/ijms131113781, 13:12, (13781-13803) STAPLETON P, MINARCHICK V, McCAWLEY M, KNUCKLES T and NURKIEWICZ T (2012) Xenobiotic Particle Exposure and Microvascular Endpoints: A Call to Arms, Microcirculation, 10.1111/j.1549-8719.2011.00137.x, 19:2, (126-142), Online publication date: 1-Feb-2012. Di Pietro A, Baluce B, Visalli G, La Maestra S, Micale R and Izzotti A (2011) Ex vivo study for the assessment of behavioral factor and gene polymorphisms in individual susceptibility to oxidative DNA damage metals-induced, International Journal of Hygiene and Environmental Health, 10.1016/j.ijheh.2011.01.006, 214:3, (210-218), Online publication date: 1-Jun-2011. Sandström T and Newby D (2011) Role of Inflammation in the Atherogenic Effects of Particulate Matter Cardiovascular Effects of Inhaled Ultrafine and Nanosized Particles, 10.1002/9780470910917.ch14, (273-285) Kodavanti U, Chen L and Costa D (2011) Experimental Studies in Animals Cardiovascular Effects of Inhaled Ultrafine and Nanosized Particles, 10.1002/9780470910917.ch10, (185-215) Thurnherr T, Su D, Diener L, Weinberg G, Manser P, Pfänder N, Arrigo R, Schuster M, Wick P and Krug H (2009) Comprehensive evaluation of in vitro toxicity of three large-scale produced carbon nanotubes on human Jurkat T cells and a comparison to crocidolite asbestos , Nanotoxicology, 10.3109/17435390903276958, 3:4, (319-338), Online publication date: 1-Dec-2009. Samet J, Rappold A, Graff D, Cascio W, Berntsen J, Huang Y, Herbst M, Bassett M, Montilla T, Hazucha M, Bromberg P and Devlin R (2009) Concentrated Ambient Ultrafine Particle Exposure Induces Cardiac Changes in Young Healthy Volunteers, American Journal of Respiratory and Critical Care Medicine, 10.1164/rccm.200807-1043OC, 179:11, (1034-1042), Online publication date: 1-Jun-2009. Related articlesUltrafine Particles: Geiser et al. Respond1 April 2006Environmental Health Perspectives Vol. 114, No. 4 April 2006Metrics About Article Metrics Publication History Originally published1 April 2006Published in print1 April 2006 Financial disclosuresPDF download License information EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. Note to readers with disabilities EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact [email protected]. Our staff will work with you to assess and meet your accessibility needs within 3 working days.